Other clinical studies revealed genetic variations in the SLC6A2 gene are associated with neuropsychiatric and/or cardiovascular disease by way of polymorphism in the 3’ end by micro RNA mechanisms (Marques et al., 2017; Hommers et al., 2018). Here, SLC6A2 is linked to cardiovascular disorder.